Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension. - Wikidata - awgldk - TriplyDB

Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension.

Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension.

http://www.wikidata.org/entity/Q37675536

about

Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension.Upregulation of canonical transient receptor potential channel in the pulmonary arterial smooth muscle of a chronic thromboembolic pulmonary hypertension rat model.Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension.Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation.EXPRESS: Are anticoagulants still indicated in pulmonary arterial hypertension?AKT-targeted anti-inflammatory activity of calyx ethanolic extract

P2860

Q35115837-A1AD400C-83F7-46BF-BFE1-A0E0F1B4D707 Q35676912-B7BDE506-0DD8-4D87-B262-21453169A46D Q35686329-97CB76F7-F81F-4775-9608-C7C931E2C0A8 Q36902375-A2FF4F4D-0632-43E1-AE98-5948F9DC188B Q54247627-44E2BCF5-30DF-4F52-A634-719FCE33E1C6 Q57031654-91AA6F24-3719-4AA1-BE82-7117DCEF648C Q58595391-C1CC0459-D1E0-453F-8C03-E7DE7507CA75

P2860

Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension.

http://www.wikidata.org/entity/Q37675536

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Thrombin-mediated activation o ...... ing in pulmonary hypertension.

@en

Thrombin-mediated activation o ...... ing in pulmonary hypertension.

@nl

type

label

Thrombin-mediated activation o ...... ing in pulmonary hypertension.

@en

Thrombin-mediated activation o ...... ing in pulmonary hypertension.

@nl

prefLabel

Thrombin-mediated activation o ...... ing in pulmonary hypertension.

@en

Thrombin-mediated activation o ...... ing in pulmonary hypertension.

@nl

P1433

Q37675536-983E27AC-30DF-4A28-8524-5E823E5E8361

P1476

Q37675536-BADF2216-8D84-4869-956A-D7B4535EA49E

P2093

Q37675536-0A164BD9-5A72-44D0-9E11-D290FAA4AAE9

Q37675536-4ECE7ADF-E94E-40D5-9AC9-43FDC5746E9E

Q37675536-778FD806-954D-47AF-9E3B-B6786DCDCC44

Q37675536-810701F4-495A-478A-9F41-E71AE37A3787

Q37675536-D13A2128-70E0-4947-9937-5200153B4EE0

Q37675536-D6E483BC-9D9C-43CF-928E-D5E91C79BC48

Q37675536-E1B39C05-9113-4B4E-A7D6-57491A2080A4

Q37675536-FEDB028E-1DA9-4E8E-8FCF-A88FAFE38480

P2860

Q37675536-0A20830B-2FAD-4EC2-A548-1DEE3EDA0BF8

Q37675536-13923F97-783A-4489-B3BF-DEEA7AC48440

Q37675536-13B37B77-9B55-4657-A65F-852E0911C254

Q37675536-14E9E4D6-B72F-48C2-ABB9-EF073F7D5669

Q37675536-14F5ECF0-8DC6-4D3D-9ED0-F66E0D0F3D68

Q37675536-1F4746CB-DF94-403E-B906-F240A0BF21FB

Q37675536-23516769-E8F2-4074-B022-E56FB97AA613

Q37675536-283A26F2-2839-4CFF-B962-5E58FCFBD2EE

Q37675536-283EB842-C834-4709-B4A7-D9D199C548AD

Q37675536-28D3695A-4E1A-4C97-AE16-165A1B801701

P304

Q37675536-575C3BA7-35A7-4FDF-9362-73C2BD77D0D8

P31

Q37675536-715A5B82-0833-4785-A750-991ED517FEC6

P356

Q37675536-9B5A325A-C8E4-4449-A6C9-320D136AD512

P433

Q37675536-99300261-0E83-4918-A44F-84D5B66A947D

P478

Q37675536-4534DF63-FF72-4BB0-9E79-64EA149EA0A7

P577

Q37675536-4910813B-88A5-498E-816B-DC088B2CA949

P5875

Q37675536-A1F2ADCC-F328-4950-B526-D0DE2A79A391

P698

Q37675536-7E652943-4828-4064-903B-6E74BAA8FA43

P921

Q37675536-D6E134B4-9451-4F32-8B0C-6477D6A22A20

P932

Q37675536-ACC068D3-7C7B-4683-8041-891DB648574F

P356

P1433

Physiological Reports

P1476

Thrombin-mediated activation o ...... ing in pulmonary hypertension.

@en

P2093

Aiko Ogawa

http://www.w3.org/2001/XMLSchema#string

Amy L Firth

http://www.w3.org/2001/XMLSchema#string

Dustin R Fraidenburg

http://www.w3.org/2001/XMLSchema#string

Hiromi Matsubara

http://www.w3.org/2001/XMLSchema#string

Ichiro Yamadori

http://www.w3.org/2001/XMLSchema#string

Jason X-J Yuan

http://www.w3.org/2001/XMLSchema#string

Sanae Ariyasu

http://www.w3.org/2001/XMLSchema#string

Shanshan Song

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Chronic thromboembolic pulmonary hypertension: Medical treatment.

Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

Direct thrombin inhibitors

Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases

Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition

Cellular survival: a play in three Akts

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Thrombin signalling and protease-activated receptors

P304

e00190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHY2.190

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259541622

http://www.w3.org/2001/XMLSchema#string

P698

24744867

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3970741

http://www.w3.org/2001/XMLSchema#string